GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » abrdn Healthcare Investors (NYSE:HQH) » Definitions » EV-to-FCF

abrdn Healthcare Investors (abrdn Healthcare Investors) EV-to-FCF : (As of Apr. 29, 2024)


View and export this data going back to . Start your Free Trial

What is abrdn Healthcare Investors EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, abrdn Healthcare Investors's Enterprise Value is $819.11 Mil. abrdn Healthcare Investors's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2023 was $0.00 Mil. Therefore, abrdn Healthcare Investors's EV-to-FCF for today is .

The historical rank and industry rank for abrdn Healthcare Investors's EV-to-FCF or its related term are showing as below:

HQH's EV-to-FCF is not ranked *
in the Asset Management industry.
Industry Median: 13.48
* Ranked among companies with meaningful EV-to-FCF only.

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-04-29), abrdn Healthcare Investors's stock price is $16.18. abrdn Healthcare Investors's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was $1.090. Therefore, abrdn Healthcare Investors's PE Ratio for today is 14.84.


abrdn Healthcare Investors EV-to-FCF Historical Data

The historical data trend for abrdn Healthcare Investors's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

abrdn Healthcare Investors EV-to-FCF Chart

abrdn Healthcare Investors Annual Data
Trend Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
EV-to-FCF
Get a 7-Day Free Trial - - - - -

abrdn Healthcare Investors Semi-Annual Data
Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of abrdn Healthcare Investors's EV-to-FCF

For the Asset Management subindustry, abrdn Healthcare Investors's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


abrdn Healthcare Investors's EV-to-FCF Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, abrdn Healthcare Investors's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where abrdn Healthcare Investors's EV-to-FCF falls into.



abrdn Healthcare Investors EV-to-FCF Calculation

abrdn Healthcare Investors's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=819.108/0
=

abrdn Healthcare Investors's current Enterprise Value is $819.11 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. abrdn Healthcare Investors's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2023 was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


abrdn Healthcare Investors  (NYSE:HQH) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

abrdn Healthcare Investors's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=16.18/1.090
=14.84

abrdn Healthcare Investors's share price for today is $16.18.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. abrdn Healthcare Investors's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was $1.090.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


abrdn Healthcare Investors EV-to-FCF Related Terms

Thank you for viewing the detailed overview of abrdn Healthcare Investors's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


abrdn Healthcare Investors (abrdn Healthcare Investors) Business Description

Traded in Other Exchanges
N/A
Address
900 Market Street, Suite 200, Philadelphia, PA, USA, 19103
abrdn Healthcare Investors Formerly Tekla Healthcare Investors is the United States based non-diversified closed-end management investment company. Its objective is to seek long-term capital appreciation by investing in securities of healthcare companies. In addition, the fund seeks to provide regular distribution of realized capital gains. The fund invests in the securities of public and private companies.
Executives
Todd Reit director C/O ABERDEEN STANDARD INVESTMENTS, 1900 MARKET STREET, SUITE 200, PHILADELPHIA PA 19103
Bill Maher director 600 WEST BROADWAY, 30TH FL., SAN DIEGO CA 92101
Alan R Goodson officer: Vice President 1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103
Rose Dimartino director C/O ABRDN, 1900 MARKET STREET, PHILADELPHIA PA 19103
James Joseph O'connor other: Director of Adviser C/O ABERDEEN STANDARD INVESTMENTS, 1900 MARKET STREET, SUITE 200, PHILADELPHIA PA 19103
Marika Tooze other: Director of Adviser C/O ABRDN, 1900 MARKET STREET, SUITE 200, PHILADELPHIA PA 19103
Aberdeen Standard Investments Inc. other: Adviser 1900 MARKET ST., 2ND FLOOR, PHILADELPHIA PA 19103
Jaclyn Marie Matsick other: Director of Adviser C/O ABRDN, 1900 MARKET STREET, SUITE 200, PHILADELPHIA PA 19103
Lucia Sitar officer: VP and Chief Legal Officer 1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103
Jennifer A Nichols other: Director of Adviser 1735 MARKET STREET, 37TH FLOOR, PHILADELPHIA PA 19103
Christian Pittard officer: President ONE BOW CHURCHYARD, LONDON X0 EC4M 9HH
Megan Kennedy officer: Secretary and Vice President 1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103
Sharon Ferrari officer: Treasurer and CFO 1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103
Joseph Andolina officer: Chief Compliance Officer & VP 1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103
Stephen Bird director 388 GREENWICH STREET, 17TH FLOOR, NEW YORK NY 10022